PI: Alice Assinger
Funded by: ACOVACT study of the Medical University Vienna is financially supported by the Austrian Federal Ministry of Education, Science and Research
Funding period: 12/2020-6/2022
Coronavirus disease 2019 (COVID-19) is a novel infectious disease, which can cause acute respiratory distress syndrome (ARDS), liver failure and multi-organ failure in 2-15 % of patients. Although the lung is the primary affected organ, several studies revealed that COVID-19 patients are also at severe risk for thrombotic complications. The features of COVID-19-associated coagulopathy are unique and incompletely understood. In this project we study the impact of coagulation- and platelet-associated parameters in a prospectively collected patient cohort with COVID-19.
VPL - Vienna Platelet Laboratories
Schwarzspanierstrasse 17
1090 Wien
